NCT07036601View on ClinicalTrials.gov

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

PHASE2RecruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

February 13, 2026

Study Completion Date

March 11, 2026

Conditions
Overweight or Obese
Interventions
DRUG

THDBH120 injection

Participants received THDBH120 by subcutaneous injection.

DRUG

Placebo of THDBH120 injection

Participants received placebo by subcutaneous injection.

Trial Locations (1)

Unknown

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Tonghua Dongbao Pharmaceutical Co.,Ltd

INDUSTRY